Meta-analysis of association of insertion/deletion polymorphism of angiotensin I-converting enzyme gene with diabetic nephropathy and retinopathy

Diabetologia

Volumn 41, Issue 1, 1998, Pages 47-53

  Fujisawa, T ^a   Ikegami, H ^a,c   Kawaguchi, Y ^a   Hamada, Y ^a   Ueda, H ^a   Shintani, M ^a   Fukuda, M ^b   Ogihara, T ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA GENERAL MEDICAL CENTER   (Japan)

^c OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin I converting enzyme gene; Diabetic nephropathy; Diabetic retinopathy; Genetic susceptibility; I D polymorphism; Meta analysis

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE;

ARTICLE; CLINICAL TRIAL; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; GENE DELETION; GENE INSERTION; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; META ANALYSIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ALLELES; CONFIDENCE INTERVALS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; DNA TRANSPOSABLE ELEMENTS; FEMALE; GENOTYPE; HUMANS; MALE; ODDS RATIO; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; SEQUENCE DELETION;

EID: 0031931515     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001250050865     Document Type: Article

References (38)

1. Leslie RDG, Pyke AD (1982) Diabetic retinopathy in identical twins. Diabetes 31: 19-21
2. Seaquist ER, Goetz FC, Rich S, Barbosa J (1989) Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165
3. Quinn M, Angelico MC, Warram JH, Krolewski AS (1996) Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 39: 940-945
4. Trevisan R, Viberti G (1995) Genetic factors in the development of diabetic nephropathy. J Lab Clin Med 126: 342-349
5. Chowdhury TA, Kumar S, Barnett AH, Bain SC (1995) Nephropathy in type 1 diabetes: the role of genetic factors. Diabet Med 12: 1059-1067
6. Erdos E, Skidgel RA (1987) The angiotensin I-converting enzyme. Lab Invest 56: 345-348
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Covol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346
8. Cambien F, Poirier O, Lancerf L, et al. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644
9. Oxman AD, Cook DJ, Guyatt GH (1994) User's guide to the medical literature: VI. How to use an overview. JAMA 272: 1367-1371
10. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748
11. Breslow NE, Day NE (1980) The analysis of case-control studies. In: Davis W (ed) Statistical methods in cancer research. Vol. 1., International Agency for Research on Cancer. Lyon, pp 173-176
12. Marre M, Bernadet P, Gallois Y, et al. (1994) Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43: 384-388
13. Doria A, Warram JH, Krolewski AS (1994) Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin I-converting enzyme gene. Diabetes 43: 690-695
14. Powrie JK, Watts GF, Ingham JN, Taub NA, Talmud PJ, Shaw KM (1994) Role of glycaemic control in development of microalbuminuria in patients with insulin dependent diabetes. Brit Med J 309: 1608-1612
15. Schmidt S, Schöne N, Ritz E (1995) Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47: 1176-1181
16. Tarnow L, Cambien F, Rossing P, et al. (1995) Lack of relationship between an insertion/deletion polymorphism in the angiotensin I-converting enzyme gene and diabetic nephropathy and proliferative retinopathy in IDDM patients. Diabetes 44: 489-494
17. Fujisawa T, Ikegami H, Shen G-Q, et al. (1995) Angiotensin I-converting enzyme gene polymorphism is associated with myocardial infarction, but not with retinopathy or nephropathy, in non-insulin-dependent diabetes mellitus. Diabetes Care 18: 983-985
18. Muzuiri S, Hemmi H, Inoue A, et al. (1995) Angiotensin-converting enzyme polymorphism and development of diabetic nephropathy in non-insulin-dependent diabetes mellitus. Nephron 70: 455-459
19. Panagiotopoulos S, Smith TJ, Aldred GP, Baker EJ, Jacklin CJ, Jerums G (1995) Angiotensin-converting enzyme (ACE) gene polymorphism in type II diabetic patients with increased albumin excretion rate. J Diabetes Complications 9: 272-276
20. Dudley CRK, Keavney B, Stratton IM, Turner RC, Ratcliffe PJ (1995) UK Prospective Diabetes Study. XV: Relationship of renin-angiotensin system gene polymorphisms with microalbuminuria in NIDDM. Kidney Int 48: 1907-1911
21. Doi Y, Yoshizumi H, Yoshinari M, et al. (1996) Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM. Diabetologia 39: 97-102
22. Ohno T, Kawazu S, Tomono S (1996) Association analysis of angiotensin-converting enzyme and angiotensinogen genes with diabetic nephropathy in Japanese non-insulin-dependent diabetes mellitus. Metabolism 45: 218-222
23. Oh TG, Shin CS, Park KS, et al. (1996) Relationship between angiotensin I converting enzyme gene polymorphism and renal complication in Korean IDDM patients. Korean J Intern Med 11: 133-137
24. Yoshida H, Kuriyama S, Atsumi Y, et al. (1996) Angiotensin I converting enzyme gene polymorphism in non-insulin dependent diabetes mellitus. Kidney Int 50: 657-664
25. Chowdhury TA, Dronsfield MJ, Kumar S, et al. (1996) Examination of two genetic polymorphisms within the renin-angiotensin system: no evidence for an association with nephropathy in IDDM. Diabetologia 39: 1108-1114
26. Nakajima S, Baba T, Yajima Y (1996) Is ACE gene polymorphism a useful marker for diabetic albuminuria in Japanese NIDDM patients? Diabetes Care 19: 1420-1422
27. Ringel J, Beige J, Kunz R, Distler A, Sharma AM (1997) Genetic variants of the renin-angiotensin system, diabetic nephropathy and hypertension. Diabetologia 40: 193-199
28. Barnas U, Schmidt A, Illievich A, et al. (1997) Evaluation of risk factors for the development of nephropathy in patients with IDDM: insertion/deletion angiotensin converting enzyme gene polymorphism, hypertension and metabolic control. Diabetologia 40: 327-331
29. Marre M, Jeunemaitre X, Gallois Y, et al. (1997) Contribution of genetic polymorphism in the renin-angiotensin system to the development of renal complications in insulin-dependent-diabetes: Génétique de la Néphropathie Diabétique (GENEDIAB) Study Group. J Clin Invest 99: 1585-1595
30. Nagi DK, Mansfield MW, Stickland MH, Grant PJ (1995) Angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism, and diabetic retinopathy in subjects with IDDM and NIDDM. Diabet Med 12: 997-1001
31. Krolewski AS, Warram JH, Rand LI, Kahn CR (1987) Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 317: 1390-1398
32. Kitamura H, Moriyama T, Izumi M, et al. (1996) Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology. Kidney Int 49: S101-S103
33. Samani NJ, Thompson JR, O'Toole L, Channer K, Woods KL (1996) A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94: 708-712
34. Harden PN, Geddes C, Rowe PA, et al. (1995) Polymorphism in angiotensin-converting enzyme gene and progression of IgA nephropathy. Lancet 345: 1540-1542
35. McLaughlin KJ, Harden PN, Ueda S, Boulton-Jones M, Connell JMC, Jardine AG (1996) The role of genetic polymorphisms of angiotensin-converting enzyme in the progression of renal diseases. Hypertension 28: 912-915
36. Ruiz J, Blanché H, Cohen N, et al. (1994) Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin-dependent diabetes mellitus. Proc Natl Acad Sci USA 91: 3662-3665
37. Keavney BD, Dudley CRK, Stratton IM, et al. (1995) UK Prospective Diabetes Study (UKPDS) 14: association of angiotensin-converting enzyme insertion/deletion polymorphism with myocardial infarction in NIDDM. Diabetologia 38: 948-952
38. Kirkwood BR (1988) Calculation of required sample size. In: Kirkwood BR (ed) Essentials of medical statistics. Blackwell Scientific Publications, Oxford, pp 191-201